In short. Why melasma-type pigment is the highest-risk indication for picosecond laser treatment, what rebound darkening looks like, and when to refuse treatment.
Key points
- Is this melasma-type pigment, and is it currently active and spreading?
- If it is, the answer is usually to treat the skin gently and wait, because an active, reactive condition is the worst possible target for an energy device.
- Laser is at most an occasional adjunct after control, never the foundation of the plan.
Melasma-type pigment is the indication where the honest answer is most often no, and it is also the indication most heavily marketed. It is a reactive, recurring condition influenced by sun, heat, hormones and inflammation, not a collection of spots sitting still in the skin. That difference changes everything about whether laser treatment helps.
Why it is different
In melasma-type pigment the pigment-producing cells are overactive and unstable. Anything that irritates the skin can provoke more pigment rather than less, which is the opposite of the usual logic of treatment. Sun exposure, heat, friction, harsh products and, in some people, laser treatment itself can all make it darker. The condition also fluctuates: it often fades in winter and deepens in summer, so improvement after a session can be seasonal rather than caused by the session.
That is why the first-line approach is topical and behavioural rather than device-based, and why a clinician who reaches for a laser first has skipped a step. Control the pigment with a topical programme, protect the skin from sun and heat, and see what the skin does over a few months before deciding whether any device has a role.
The question a cautious clinician asks first
Is this melasma-type pigment, and is it currently active and spreading? If it is, the answer is usually to treat the skin gently and wait, because an active, reactive condition is the worst possible target for an energy device. Laser is at most an occasional adjunct after control, never the foundation of the plan.
When laser is considered, and how
Where laser treatment is used at all in this condition, it tends to be cautious: a test area first, gentle passes, wide intervals, and a clear agreement that the aim is modest improvement rather than clearance. Even then the result is unpredictable. Some people improve, some do not, and the improvement often fades over the following months.
The pattern that causes harm is repetition. Each session followed by rebound darkening is followed by another session to fix it, and the skin becomes progressively more reactive. Recognising that loop early is worth more than any adjustment to technique.
When to refuse or stop
- The pigment is active, spreading or recently provoked by sun or heat — treatment should wait until it settles.
- A series has produced rebound darkening rather than gradual lightening; more sessions in that pattern tend to deepen the problem.
- You are not able or willing to maintain daily sun protection. Without it, any improvement here is brief and the risk is not.
For melasma-type pigment, the honest position is that laser is not the treatment, and sometimes not a treatment at all. It can be a small part of a longer plan built on topical control and photoprotection, and in the wrong circumstances it leaves the skin worse than it started. A clinic that says so is telling you something more useful than any promise of clearance.
Frequently asked questions
Can a picosecond laser cure melasma-type pigment?
No. It is a recurring condition influenced by sun, heat, hormones and inflammation, and no device removes those causes. A laser can occasionally be a small part of a longer plan built on topical control and photoprotection, and even then the improvement is unpredictable and often fades.
What is rebound darkening?
It is the skin producing more pigment after treatment instead of less, so the treated area becomes darker than it was before the session. In a reactive condition it is a recognised response, and repeating the treatment that caused it tends to deepen the problem rather than settle it.
Is it worth trying one session to see?
Only with a clear agreement about what would count as a failure and what happens next. A single cautious session on a small test area is a reasonable way to learn how your skin behaves. A full-face course booked in advance is not, because this is the condition most likely to be worsened by treatment.
Risks & Limitations
- Post-inflammatory hyperpigmentation — the treated area becoming darker than it was — is the most common unwanted outcome. It is more likely in darker skin, after recent sun exposure and when sessions are spaced too closely together.
- Hypopigmentation, where treated skin becomes paler than its surroundings, is less common than darkening and can be long-lasting.
- Scarring is uncommon but real, and more likely when skin is treated aggressively or repeatedly.
- Blistering, infection and reactivation of cold sores occur occasionally.
- Melasma-type pigment can become more reactive with repeated treatment and may worsen rather than improve.
- Results are incremental, usually need several sessions, and are not permanent. Pigment often returns over months and years.
- A pigmented lesion that is new or changing should be examined rather than treated, and no cosmetic treatment should delay that assessment.
When to Seek Care
- Blistering, weeping or broken skin beyond the expected reaction.
- Spreading redness, warmth, pus or fever.
- Pain that is worsening rather than settling after the first day.
- Treated skin that becomes paler than its surroundings, or that keeps darkening week after week.
- A new, changing, itching or bleeding lesion, whether or not it has been treated.
References & Further Reading
- American Academy of Dermatology (AAD) — pigment, laser and tattoo removal information
- American Society for Laser Medicine & Surgery (ASLMS)
- National Medical Products Administration (NMPA, China) — device registration status
- Cochrane Library — systematic reviews in laser dermatology and pigmentation
This page is patient education, not medical advice, and it does not cite individual studies. Discuss your own case with a qualified clinician. To arrange an assessment at Chongqing West District Hospital, see Contact & Consultation.